Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Allergy Diagnostics and Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Allergy Diagnostics and Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 142 Pages
Report ld: 5345149
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Allergy Diagnostics and Testing Market Size(US$)
CAGR 2025-2031
8.4%
Market Size,2031
USD 2,519
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,553 million
Market Forecast in 2031(Value)
US$ 2,519 million
CAGR
8.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Allergy Diagnostics and Testing market is projected to grow from US$ 1443 million in 2024 to US$ 2519 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
The Allergy Diagnostics Reagent market is driven by the increasing prevalence of allergic disorders and the growing demand for accurate and early diagnosis. Allergies have become a global health concern, affecting a significant portion of the population, and there is a rising awareness about the importance of identifying allergens to manage symptoms effectively. The development of advanced allergy diagnostics reagents, including allergen extracts, specific IgE tests, and molecular assays, has improved the accuracy and specificity of allergy testing, contributing to market growth. Moreover, the adoption of personalized medicine approaches and the emphasis on targeted treatments align with the need for precise allergy diagnosis to tailor therapies for individual patients. However, the market also faces challenges, including the diversity of allergens and the complexity of immune responses, making accurate diagnosis complex. Additionally, addressing regulatory approvals, standardization of testing procedures, and reimbursement issues pose obstacles for manufacturers and healthcare providers. To succeed, stakeholders must focus on continuous innovation in reagent development, expanding the range of detectable allergens, and collaborating with healthcare systems to ensure accurate and accessible allergy diagnostics for patients. Addressing challenges while providing reliable and comprehensive allergy testing solutions will drive market growth and contribute to better allergy management and patient outcomes.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Allergy Diagnostics and Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- BioMerieux
- Minaris Medical America
- PerkinElmer
- HAL Allergy Group
- Siemens Healthineers
- Stallergenes Greer
- HOB Biotech Group
- Lincoln Diagnostics
- MEDIWISS Analytic
- Danaher
- Hycor Biomedical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
Segment by Application
- Diagnostic Laboratories
- Hospital-based Laboratories
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Allergy Diagnostics and Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Allergy Diagnostics and Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Allergy Diagnostics and Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Inhaled Allergens
1.2.3 Food Allergens
1.2.4 Drug Allergens
1.2.5 Other Allergens
1.3 Market Segmentation by Application
1.3.1 Global Allergy Diagnostics and Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospital-based Laboratories
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergy Diagnostics and Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Allergy Diagnostics and Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Allergy Diagnostics and Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Allergy Diagnostics and Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Inhaled Allergens Market Size by Players
3.3.2 Food Allergens Market Size by Players
3.3.3 Drug Allergens Market Size by Players
3.3.4 Other Allergens Market Size by Players
3.4 Global Allergy Diagnostics and Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Allergy Diagnostics and Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Allergy Diagnostics and Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Allergy Diagnostics and Testing Market Size by Type (2020-2031)
6.4 North America Allergy Diagnostics and Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Allergy Diagnostics and Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Allergy Diagnostics and Testing Market Size by Type (2020-2031)
7.4 Europe Allergy Diagnostics and Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Allergy Diagnostics and Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Allergy Diagnostics and Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Allergy Diagnostics and Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Allergy Diagnostics and Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Allergy Diagnostics and Testing Market Size by Type (2020-2031)
9.4 Central and South America Allergy Diagnostics and Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Allergy Diagnostics and Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Allergy Diagnostics and Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Allergy Diagnostics and Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Allergy Diagnostics and Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Allergy Diagnostics and Testing Product Features and Attributes
11.1.4 Thermo Fisher Scientific Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Allergy Diagnostics and Testing Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Allergy Diagnostics and Testing Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Allergy Diagnostics and Testing Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Allergy Diagnostics and Testing SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 BioMerieux
11.2.1 BioMerieux Corporation Information
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Allergy Diagnostics and Testing Product Features and Attributes
11.2.4 BioMerieux Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.2.5 BioMerieux Allergy Diagnostics and Testing Revenue by Product in 2024
11.2.6 BioMerieux Allergy Diagnostics and Testing Revenue by Application in 2024
11.2.7 BioMerieux Allergy Diagnostics and Testing Revenue by Geographic Area in 2024
11.2.8 BioMerieux Allergy Diagnostics and Testing SWOT Analysis
11.2.9 BioMerieux Recent Developments
11.3 Minaris Medical America
11.3.1 Minaris Medical America Corporation Information
11.3.2 Minaris Medical America Business Overview
11.3.3 Minaris Medical America Allergy Diagnostics and Testing Product Features and Attributes
11.3.4 Minaris Medical America Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.3.5 Minaris Medical America Allergy Diagnostics and Testing Revenue by Product in 2024
11.3.6 Minaris Medical America Allergy Diagnostics and Testing Revenue by Application in 2024
11.3.7 Minaris Medical America Allergy Diagnostics and Testing Revenue by Geographic Area in 2024
11.3.8 Minaris Medical America Allergy Diagnostics and Testing SWOT Analysis
11.3.9 Minaris Medical America Recent Developments
11.4 PerkinElmer
11.4.1 PerkinElmer Corporation Information
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Allergy Diagnostics and Testing Product Features and Attributes
11.4.4 PerkinElmer Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.4.5 PerkinElmer Allergy Diagnostics and Testing Revenue by Product in 2024
11.4.6 PerkinElmer Allergy Diagnostics and Testing Revenue by Application in 2024
11.4.7 PerkinElmer Allergy Diagnostics and Testing Revenue by Geographic Area in 2024
11.4.8 PerkinElmer Allergy Diagnostics and Testing SWOT Analysis
11.4.9 PerkinElmer Recent Developments
11.5 HAL Allergy Group
11.5.1 HAL Allergy Group Corporation Information
11.5.2 HAL Allergy Group Business Overview
11.5.3 HAL Allergy Group Allergy Diagnostics and Testing Product Features and Attributes
11.5.4 HAL Allergy Group Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.5.5 HAL Allergy Group Allergy Diagnostics and Testing Revenue by Product in 2024
11.5.6 HAL Allergy Group Allergy Diagnostics and Testing Revenue by Application in 2024
11.5.7 HAL Allergy Group Allergy Diagnostics and Testing Revenue by Geographic Area in 2024
11.5.8 HAL Allergy Group Allergy Diagnostics and Testing SWOT Analysis
11.5.9 HAL Allergy Group Recent Developments
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Corporation Information
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Allergy Diagnostics and Testing Product Features and Attributes
11.6.4 Siemens Healthineers Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.6.5 Siemens Healthineers Recent Developments
11.7 Stallergenes Greer
11.7.1 Stallergenes Greer Corporation Information
11.7.2 Stallergenes Greer Business Overview
11.7.3 Stallergenes Greer Allergy Diagnostics and Testing Product Features and Attributes
11.7.4 Stallergenes Greer Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.7.5 Stallergenes Greer Recent Developments
11.8 HOB Biotech Group
11.8.1 HOB Biotech Group Corporation Information
11.8.2 HOB Biotech Group Business Overview
11.8.3 HOB Biotech Group Allergy Diagnostics and Testing Product Features and Attributes
11.8.4 HOB Biotech Group Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.8.5 HOB Biotech Group Recent Developments
11.9 Lincoln Diagnostics
11.9.1 Lincoln Diagnostics Corporation Information
11.9.2 Lincoln Diagnostics Business Overview
11.9.3 Lincoln Diagnostics Allergy Diagnostics and Testing Product Features and Attributes
11.9.4 Lincoln Diagnostics Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.9.5 Lincoln Diagnostics Recent Developments
11.10 MEDIWISS Analytic
11.10.1 MEDIWISS Analytic Corporation Information
11.10.2 MEDIWISS Analytic Business Overview
11.10.3 MEDIWISS Analytic Allergy Diagnostics and Testing Product Features and Attributes
11.10.4 MEDIWISS Analytic Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Danaher
11.11.1 Danaher Corporation Information
11.11.2 Danaher Business Overview
11.11.3 Danaher Allergy Diagnostics and Testing Product Features and Attributes
11.11.4 Danaher Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.11.5 Danaher Recent Developments
11.12 Hycor Biomedical
11.12.1 Hycor Biomedical Corporation Information
11.12.2 Hycor Biomedical Business Overview
11.12.3 Hycor Biomedical Allergy Diagnostics and Testing Product Features and Attributes
11.12.4 Hycor Biomedical Allergy Diagnostics and Testing Revenue and Gross Margin (2020-2025)
11.12.5 Hycor Biomedical Recent Developments
12 Allergy Diagnostics and TestingIndustry Chain Analysis
12.1 Allergy Diagnostics and Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Allergy Diagnostics and Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Allergy Diagnostics and Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Allergy Diagnostics and Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Allergy Diagnostics and Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Allergy Diagnostics and Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Allergy Diagnostics and Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Allergy Diagnostics and Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Allergy Diagnostics and Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Allergy Diagnostics and Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Diagnostics and Testing as of 2024)
Table 11. Global Allergy Diagnostics and Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Allergy Diagnostics and Testing Companies Headquarters
Table 13. Global Allergy Diagnostics and Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Allergy Diagnostics and Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Allergy Diagnostics and Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Allergy Diagnostics and Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Allergy Diagnostics and Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Allergy Diagnostics and Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Allergy Diagnostics and Testing Growth Accelerators and Market Barriers
Table 25. North America Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Allergy Diagnostics and Testing Growth Accelerators and Market Barriers
Table 27. Europe Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Allergy Diagnostics and Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Allergy Diagnostics and Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Allergy Diagnostics and Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Allergy Diagnostics and Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Allergy Diagnostics and Testing SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. BioMerieux Corporation Information
Table 44. BioMerieux Description and Major Businesses
Table 45. BioMerieux Product Features and Attributes
Table 46. BioMerieux Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. BioMerieux Revenue Proportion by Product in 2024
Table 48. BioMerieux Revenue Proportion by Application in 2024
Table 49. BioMerieux Revenue Proportion by Geographic Area in 2024
Table 50. BioMerieux Allergy Diagnostics and Testing SWOT Analysis
Table 51. BioMerieux Recent Developments
Table 52. Minaris Medical America Corporation Information
Table 53. Minaris Medical America Description and Major Businesses
Table 54. Minaris Medical America Product Features and Attributes
Table 55. Minaris Medical America Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Minaris Medical America Revenue Proportion by Product in 2024
Table 57. Minaris Medical America Revenue Proportion by Application in 2024
Table 58. Minaris Medical America Revenue Proportion by Geographic Area in 2024
Table 59. Minaris Medical America Allergy Diagnostics and Testing SWOT Analysis
Table 60. Minaris Medical America Recent Developments
Table 61. PerkinElmer Corporation Information
Table 62. PerkinElmer Description and Major Businesses
Table 63. PerkinElmer Product Features and Attributes
Table 64. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. PerkinElmer Revenue Proportion by Product in 2024
Table 66. PerkinElmer Revenue Proportion by Application in 2024
Table 67. PerkinElmer Revenue Proportion by Geographic Area in 2024
Table 68. PerkinElmer Allergy Diagnostics and Testing SWOT Analysis
Table 69. PerkinElmer Recent Developments
Table 70. HAL Allergy Group Corporation Information
Table 71. HAL Allergy Group Description and Major Businesses
Table 72. HAL Allergy Group Product Features and Attributes
Table 73. HAL Allergy Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. HAL Allergy Group Revenue Proportion by Product in 2024
Table 75. HAL Allergy Group Revenue Proportion by Application in 2024
Table 76. HAL Allergy Group Revenue Proportion by Geographic Area in 2024
Table 77. HAL Allergy Group Allergy Diagnostics and Testing SWOT Analysis
Table 78. HAL Allergy Group Recent Developments
Table 79. Siemens Healthineers Corporation Information
Table 80. Siemens Healthineers Description and Major Businesses
Table 81. Siemens Healthineers Product Features and Attributes
Table 82. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Siemens Healthineers Recent Developments
Table 84. Stallergenes Greer Corporation Information
Table 85. Stallergenes Greer Description and Major Businesses
Table 86. Stallergenes Greer Product Features and Attributes
Table 87. Stallergenes Greer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Stallergenes Greer Recent Developments
Table 89. HOB Biotech Group Corporation Information
Table 90. HOB Biotech Group Description and Major Businesses
Table 91. HOB Biotech Group Product Features and Attributes
Table 92. HOB Biotech Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. HOB Biotech Group Recent Developments
Table 94. Lincoln Diagnostics Corporation Information
Table 95. Lincoln Diagnostics Description and Major Businesses
Table 96. Lincoln Diagnostics Product Features and Attributes
Table 97. Lincoln Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Lincoln Diagnostics Recent Developments
Table 99. MEDIWISS Analytic Corporation Information
Table 100. MEDIWISS Analytic Description and Major Businesses
Table 101. MEDIWISS Analytic Product Features and Attributes
Table 102. MEDIWISS Analytic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. MEDIWISS Analytic Recent Developments
Table 104. Danaher Corporation Information
Table 105. Danaher Description and Major Businesses
Table 106. Danaher Product Features and Attributes
Table 107. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Danaher Recent Developments
Table 109. Hycor Biomedical Corporation Information
Table 110. Hycor Biomedical Description and Major Businesses
Table 111. Hycor Biomedical Product Features and Attributes
Table 112. Hycor Biomedical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Hycor Biomedical Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Diagnostics and Testing Product Picture
Figure 2. Global Allergy Diagnostics and Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Inhaled Allergens Product Picture
Figure 4. Food Allergens Product Picture
Figure 5. Drug Allergens Product Picture
Figure 6. Other Allergens Product Picture
Figure 7. Global Allergy Diagnostics and Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Diagnostic Laboratories
Figure 9. Hospital-based Laboratories
Figure 10. Other
Figure 11. Allergy Diagnostics and Testing Report Years Considered
Figure 12. Global Allergy Diagnostics and Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 14. Global Allergy Diagnostics and Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Allergy Diagnostics and Testing Revenue Market Share by Region (2020-2031)
Figure 16. Global Allergy Diagnostics and Testing Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Inhaled Allergens Revenue Market Share by Player in 2024
Figure 19. Food Allergens Revenue Market Share by Player in 2024
Figure 20. Drug Allergens Revenue Market Share by Player in 2024
Figure 21. Other Allergens Revenue Market Share by Player in 2024
Figure 22. Global Allergy Diagnostics and Testing Revenue Market Share by Type (2020-2031)
Figure 23. Global Allergy Diagnostics and Testing Revenue Market Share by Application (2020-2031)
Figure 24. North America Allergy Diagnostics and Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Allergy Diagnostics and Testing Revenue (US$ Million) in 2024
Figure 26. North America Allergy Diagnostics and Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Allergy Diagnostics and Testing Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Allergy Diagnostics and Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Allergy Diagnostics and Testing Revenue (US$ Million) in 2024
Figure 33. Europe Allergy Diagnostics and Testing Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Allergy Diagnostics and Testing Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 36. France Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Allergy Diagnostics and Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Allergy Diagnostics and Testing Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Allergy Diagnostics and Testing Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Allergy Diagnostics and Testing Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 48. India Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Allergy Diagnostics and Testing Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Allergy Diagnostics and Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Allergy Diagnostics and Testing Revenue (US$ Million) in 2024
Figure 56. Central and South America Allergy Diagnostics and Testing Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Allergy Diagnostics and Testing Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Allergy Diagnostics and Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Allergy Diagnostics and Testing Revenue (US$ Million) in 2024
Figure 62. South America Allergy Diagnostics and Testing Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Allergy Diagnostics and Testing Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Allergy Diagnostics and Testing Revenue (2020-2025) & (US$ Million)
Figure 68. Allergy Diagnostics and Testing Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Allergy Diagnostics and Testing in 2031?
The global market size of Allergy Diagnostics and Testing in 2031 was 2519 Million USD.
Which companies rank high in the global Allergy Diagnostics and Testing market?
Which region is expected to have the highest market share?
What was the global market size of Allergy Diagnostics and Testing in 2025?
What is the annual compound growth rate of the global Allergy Diagnostics and Testing market size from 2025 to 2031?
Related Reports
Allergy Diagnostics and Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1553 million in 2025 and is projected to reach US$ 2709 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 120
USD 3950.00
(Single User License)
Global Allergy Diagnostics and Testing Market Research Report 2026
The global Allergy Diagnostics and Testing market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 2709 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
Global Allergy Diagnostics and Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Allergy Diagnostics and Testing market size was US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
Global Allergy Diagnostics and Testing Market Research Report 2025
The global market for Allergy Diagnostics and Testing was valued at US$ 1443 million in the year 2024 and is projected to reach a revised size of US$ 2519 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published Date: 2025-01-16
Pages: 85
USD 2900.00
(Single User License)
Allergy Diagnostics and Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 113
USD 3950.00
(Single User License)
Global Allergy Diagnostics and Testing Market Insights, Forecast to 2030
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-04-12
Pages: 112
USD 4900.00
(Single User License)
Global Allergy Diagnostics and Testing Market Research Report 2024
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-01-12
Pages: 88
USD 2900.00
(Single User License)
Allergy Diagnostics and Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-01-08
Pages: 109
USD 3950.00
(Single User License)
Allergy Diagnostics and Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1553 million in 2025 and is projected to reach US$ 2709 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 120
USD 3950.00 (Single User License)Global Allergy Diagnostics and Testing Market Research Report 2026
The global Allergy Diagnostics and Testing market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 2709 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-04-17
Pages: 111
USD 2900.00 (Single User License)Global Allergy Diagnostics and Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Allergy Diagnostics and Testing market size was US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
USD 4250.00 (Single User License)Global Allergy Diagnostics and Testing Market Research Report 2025
The global market for Allergy Diagnostics and Testing was valued at US$ 1443 million in the year 2024 and is projected to reach a revised size of US$ 2519 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published: 2025-01-16
Pages: 85
USD 2900.00 (Single User License)Allergy Diagnostics and Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 113
USD 3950.00 (Single User License)Global Allergy Diagnostics and Testing Market Insights, Forecast to 2030
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-04-12
Pages: 112
USD 4900.00 (Single User License)Global Allergy Diagnostics and Testing Market Research Report 2024
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-01-12
Pages: 88
USD 2900.00 (Single User License)Allergy Diagnostics and Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-01-08
Pages: 109
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now